Icon Advisers’s GSK GSK Stock Holding History

Icon Advisers’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.72M	Hold	32,800	–	–	0.32%	107
2026 Q1	$1.81M	Hold	32,800	–	–	0.42%	87
2025 Q4	$1.61M	Sell	32,800 -3,000	-8%	-$140K	0.35%	109
2025 Q3	$1.55M	Hold	35,800	–	–	0.34%	107
2025 Q2	$1.37M	Hold	35,800	–	–	0.31%	115
2025 Q1	$1.39M	Hold	35,800	–	–	0.32%	115
2024 Q4	$1.21M	Hold	35,800	–	–	0.27%	126
2024 Q3	$1.46M	Sell	35,800 -17,200	-32%	-$704K	0.31%	123
2024 Q2	$2.03M	Sell	53,000 -11,800	-18%	-$496K	0.46%	99
2024 Q1	$2.75M	Hold	64,800	–	–	0.6%	66
2023 Q4	$2.4M	Hold	64,800	–	–	0.55%	78
2023 Q3	$2.35M	Hold	64,800	–	–	0.58%	69
2023 Q2	$2.31M	Buy	+64,800	New	+$2.32M	0.59%	67

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Icon Advisers's GSK Position: Q2 2026 in Review

Icon Advisers held its GSK (GSK) position steady in Q2 2026 at 32,800 shares worth $1.72M. The position accounts for 0.32% of the portfolio, ranked #107.

Icon Advisers first reported a position in GSK in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.75M in Q1 2024. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Icon Advisers held 32,800 shares of GSK worth $1.72M as of Q2 2026.
Icon Advisers left its GSK share count unchanged in Q2 2026.
GSK made up 0.32% of Icon Advisers's portfolio in Q2 2026, its #107 holding.
Icon Advisers first reported a position in GSK in Q2 2023 and has held it in 13 quarters since.
Icon Advisers's GSK position peaked at $2.75M in Q1 2024.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Icon Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.